Skip to main content
SpringerLink
Log in

Sibutramine: panel votes for harsher restrictions or withdrawal

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Endocrine today.FDA Advisory Committee undecided on withdrawal of sibutramine from market. Internet Document: [2 pages], 16 Sep 2010. Available from: URL: http://www.endocrinetoday.com

  2. Wood S.FDA advisors say sibutramine's CV risks warrant harsher restrictions or withdrawal. Internet Document: [1 page], 15 Sep 2010. Available from: URL: http://www.theheart.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sibutramine: panel votes for harsher restrictions or withdrawal. React. Wkly. 1320, 3 (2010). https://doi.org/10.2165/00128415-201013200-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013200-00006

Keywords

Search

Navigation